Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated

Neuroscience Letters

Volumn 592, Issue , 2015, Pages 54-58

  Brickman, Adam M ^a,b   Guzman, Vanessa A ^a   Gonzalez Castellon, Miguel ^a   Razlighi, Qolamreza ^a   Gu, Yian ^a   Narkhede, Atul ^a   Janicki, Sarah ^a,b   Ichise, Masanori ^a   Stern, Yaakov ^a,b   Manly, Jennifer J ^a,b   Schupf, Nicole ^a,b,c   Marshall, Randolph S ^a  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain College of Physicians and Surgeons Columbia University ^*  (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Department of Medicine   (United States)

Author keywords

's disease; Alzheimer; Amyloid; Cerebral autoregulation; White matter hyperintensities

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOREGULATION; BRAIN SIZE; CARDIOVASCULAR RISK; CEREBRAL AUTOREGULATION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER; WHITE MATTER HYPERINTENSITY; BRAIN; HEMODYNAMICS; METABOLISM; PATHOLOGY; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID; BRAIN; CEREBROVASCULAR DISORDERS; FEMALE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; WHITE MATTER;

EID: 84924255910     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.03.005     Document Type: Article

References (43)

1. Aaslid R., Lindegaard K.F., Sorteberg W., Nornes H. Cerebral autoregulation dynamics in humans. Stroke J. Cereb. Circulation 1989, 20:45-52.
2. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2010, 7:270-279.
3. Austin S.A., Santhanam A.V., Katusic Z.S. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ. Res. 2010, 107:1498-1502.
4. Bar K.J., Boettger M.K., Seidler N., Mentzel H.J., Terborg C., Sauer H. Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. Stroke J. Cereb. Circulation 2007, 38:3186-3192.
5. Barthel H., Gertz H.J., Dresel S., Peters O., Bartenstein P., Buerger K., Hiemeyer F., Wittemer-Rump S.M., Seibyl J., Reininger C., Sabri O. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011, 10:424-435.
6. Breteler M.M.B. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 2000, 21:153-160.
7. Brickman A.M. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Curr. Neurol. Neurosci. Rep. 2013, 13:415.
8. Brickman A.M., Honig L.S., Scarmeas N., Tatarina O., Sanders L., Albert M.S., Brandt J., Blacker D., Stern Y. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch. Neurol. 2008, 65:1202-1208.
9. Brickman A.M., Muraskin J., Zimmerman M.E. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?. Dialogues Clin. Neurosci. 2009, 11:181-190.
10. Brickman A.M., Provenzano F.A., Muraskin J., Manly J.J., Blum S., Apa Z., Stern Y., Brown T.R., Luchsinger J.A., Mayeux R. Regional white matter hyperintensity volume not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch. Neurol. 2012, 69:1621-1627.
11. Brickman A.M., Schupf N., Manly J.J., Luchsinger J.A., Andrews H., Tang M.X., Reitz C., Small S.A., Mayeux R., DeCarli C., Brown T.R. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch. Neurol. 2008, 65:1053-1061.
12. Brickman A.M., Sneed J.R., Provenzano F.A., Garcon E., Johnert L., Muraskin J., Yeung L.K., Zimmerman M.E., Roose S.P. Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res. Neuroimag. 2011, 193:101-106.
13. Brickman A.M., Zahodne L.B., Guzman V.A., Narkhede A., Provenzano F.A., Schupf N., Manly J.J., Stern Y., Luchsinger J.A., Mayeux R. Reconsidering harbingers of dementia: progression of white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol. Aging 2015, 36:27-32.
14. Chow N., Bell R.D., Deane R., Streb J.W., Chen J., Brooks A., Van Nostrand W., Miano J.M., Zlokovic B.V. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:823-828.
15. Claassen J.A., Diaz-Arrastia R., Martin-Cook K., Levine B.D., Zhang R. Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J. Alzheimers Dis. 2009, 17:621-629.
16. Claassen J.A., Levine B.D., Zhang R. Dynamic cerebral autoregulation during repeated squat-stand maneuvers. J. Appl. Physiol. (1985) 2009, 106:153-160.
17. Claassen J.A., Zhang R. Cerebral autoregulation in Alzheimer's disease. J. Cereb. Blood Flow Metab. 2011, 31:1572-1577.
18. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3:184-190.
19. Diehl R.R., Linden D., Lucke D., Berlit P. Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation. Stroke J. Cereb. Circulation 1995, 26:1801-1804.
20. Gommer E.D., Shijaku E., Mess W.H., Reulen J.P. Dynamic cerebral autoregulation: different signal processing methods without influence on results and reproducibility. Med. Biol. Eng. Comput. 2010, 48:1243-1250.
21. Iadecola C., Zhang F., Niwa K., Eckman C., Turner S.K., Fischer E., Younkin S., Borchelt D.R., Hsiao K.K., Carlson G.A. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 1999, 2:157-161.
22. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
23. Kalaria R.N. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol. Aging 2009, 30:1512-1514.
24. Kuo H.K., Lipsitz L.A. Cerebral white matter changes and geriatric syndromes: is there a link?. J. Gerontol. 2004, 59:818-826.
25. Kuo T.B., Chern C.M., Yang C.C., Hsu H.Y., Wong W.J., Sheng W.Y., Hu H.H. Mechanisms underlying phase lag between systemic arterial blood pressure and cerebral blood flow velocity. Cerebrovas. Dis. (Basel Switzerland) 2003, 16:402-409.
26. Luchsinger J.A., Brickman A.M., Reitz C., Cho S.J., Schupf N., Manly J.J., Tang M.X., Small S.A., Mayeux R., DeCarli C., Brown T.R. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology 2009, 73:450-456.
27. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2010, 7:263-269.
28. Meier I.B., Gu Y., Guzaman V.A., Wiegman A.F., Schupf N., Manly J.J., Luchsinger J.A., Viswanathan A., Martinez-Ramirez S., Greenberg S.M., Mayeux R., Brickman A.M. Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovas. Dis. 2014, 38:377-383.
29. Mueggler T., Sturchler-Pierrat C., Baumann D., Rausch M., Staufenbiel M., Rudin M. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J. Neurosci. 2002, 22:7218-7224.
30. Niwa K., Kazama K., Younkin S.G., Carlson G.A., Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis. 2002, 9:61-68.
31. Ortega-Gutierrez S., Petersen N., Masurkar A., Reccius A., Huang A., Li M., Choi J.H., Marshall R.S. Reliability, asymmetry, and age influence on dynamic cerebral autoregulation measured by spontaneous fluctuations of blood pressure and cerebral blood flow velocities in healthy individuals. J. Neuroimag. 2014, 24:379-386.
32. Paulson O.B., Strandgaard S., Edvinsson L. Cerebral autoregulation. Cerebrovas. Brain Metab. Rev. 1990, 2:161-192.
33. Petersen N.H., Ortega-Gutierrez S., Reccius A., Masurkar A., Huang A., Marshall R.S. Comparison of non-invasive and invasive arterial blood pressure measurement for assessment of dynamic cerebral autoregulation. Neurocrit. Care 2014, 20:60-68.
34. Poels M.M., Zaccai K., Verwoert G.C., Vernooij M.W., Hofman A., van der Lugt A., Witteman J.C., Breteler M.M., Mattace-Raso F.U., Ikram M.A. Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan study. Stroke J. Cereb. Circulation 2012, 43:2637-2642.
35. Provenzano F.A., Muraskin J., Tosto G., Narkhede A., Wasserman B.T., Griffith E.Y., Guzman V.A., Meier I.B., Zimmerman M.E., Brickman A.M. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?. JAMA Neurol. 2013, 70:455-461.
36. Purkayastha S., Fadar O., Mehregan A., Salat D.H., Moscufo N., Meier D.S., Guttmann C.R., Fisher N.D., Lipsitz L.A., Sorond F.A. Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J. Cereb. Blood Flow Metab. 2014, 34:228-234.
37. Reinhard M., Muller T., Guschlbauer B., Timmer J., Hetzel A. Transfer function analysis for clinical evaluation of dynamic cerebral autoregulation - a comparison between spontaneous and respiratory-induced oscillations. Physiol. Meas. 2003, 24:27-43.
38. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2010, 7:280-292.
39. Stefani A., Sancesario G., Pierantozzi M., Leone G., Galati S., Hainsworth A.H., Diomedi M. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J. Neurol. Sci. 2009, 283:109-115.
40. van Beek A.H., Claassen J.A., Rikkert M.G., Jansen R.W. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J. Cereb. Blood Flow Metab. 2008, 28:1071-1085.
41. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R., Lindley R.I., O'Brien J.T., Barkhof F., Benavente O.R., Black S.E., Brayne C., Breteler M., Chabriat H., Decarli C., de Leeuw F.E., Doubal F., Duering M., Fox N.C., Greenberg S., Hachinski V., Kilimann I., Mok V., Oostenbrugge R., Pantoni L., Speck O., Stephan B.C., Teipel S., Viswanathan A., Werring D., Chen C., Smith C., van Buchem M., Norrving B., Gorelick P.B., Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013, 12:822-838.
42. Zazulia A.R., Videen T.O., Morris J.C., Powers W.J. Autoregulation of cerebral blood flow to changes in arterial pressure in mild Alzheimer's disease. J. Cereb. Blood Flow Metab. 2010, 30:1883-1889.
43. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. 2011, 12:723-738.